These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 508663)
1. The effect of menopausal status and sequential mestranol and norethisterone on serum cholesterol, triglyceride and electrophoretic lipoprotein patterns. Paterson ME; Sturdee DW; Moore B; Whitehead TP Br J Obstet Gynaecol; 1979 Oct; 86(10):810-5. PubMed ID: 508663 [TBL] [Abstract][Full Text] [Related]
2. The effect of various regimens of hormone therapy on serum cholesterol and triglyceride concentrations in postmenopausal women. Paterson ME; Sturdee DW; Moore B; Whitehead TP Br J Obstet Gynaecol; 1980 Jul; 87(7):552-60. PubMed ID: 6252948 [TBL] [Abstract][Full Text] [Related]
3. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796 [TBL] [Abstract][Full Text] [Related]
4. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785 [TBL] [Abstract][Full Text] [Related]
5. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles. Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353 [TBL] [Abstract][Full Text] [Related]
6. Effect of a controlled exercise program on serum lipoprotein levels in women on oral contraceptives. Wynne TP; Frey MA; Laubach LL; Glueck CJ Metabolism; 1980 Dec; 29(12):1267-71. PubMed ID: 7453571 [TBL] [Abstract][Full Text] [Related]
7. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate. Furuhjelm M; Carlström K Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703 [TBL] [Abstract][Full Text] [Related]
8. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404 [TBL] [Abstract][Full Text] [Related]
9. The effect of sequential mestranol-norethisterone on the circulating lipid levels of pre- and post-menopausal women, and its possible significance. Magnani HN; Moore B Postgrad Med J; 1976; 52 Suppl 6():55-9. PubMed ID: 981121 [No Abstract] [Full Text] [Related]
10. The effect of menopausal status and sequential mestranol and norethisterone on serum biochemical profiles. Moore B; Paterson ME; Sturdee DW; Whitehead TP Br J Obstet Gynaecol; 1981 Aug; 88(8):853-8. PubMed ID: 7260006 [TBL] [Abstract][Full Text] [Related]
11. Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides. Nerbrand C; Nyberg P; Nordström L; Samsioe G Maturitas; 2002 May; 42(1):55-62. PubMed ID: 12020980 [TBL] [Abstract][Full Text] [Related]
12. Ten years post-menopausal hormone replacement therapy--effect on lipoproteins. Hart DM; Farish E; Fletcher CD; Howie C; Kitchener H Maturitas; 1984 Apr; 5(4):271-6. PubMed ID: 6738373 [TBL] [Abstract][Full Text] [Related]
13. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. Hirvonen E; Mälkönen M; Manninen V N Engl J Med; 1981 Mar; 304(10):560-3. PubMed ID: 7453723 [TBL] [Abstract][Full Text] [Related]
14. Effects of oral contraceptives on lipoprotein triglyceride and cholesterol: relationships to estrogen and progestin potency. Knopp RH; Walden CE; Wahl PW; Hoover JJ Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):725-31. PubMed ID: 7065054 [TBL] [Abstract][Full Text] [Related]
15. Serum lipids during oestradiol-valerate/norgestrel treatment of menopausal women. Double-blind study of a sequential preparation. Christensen NC; Davidsen PC; Secher NJ; Pedersen GT Acta Obstet Gynecol Scand; 1975; 54(3):213-6. PubMed ID: 1099859 [TBL] [Abstract][Full Text] [Related]
16. A long-term study of the effects of norethisterone on lipoprotein metabolism in menopausal women. Farish E; Fletcher CD; Hart DM; Kitchener H; Sharpe GL Clin Chim Acta; 1983 Aug; 132(2):193-8. PubMed ID: 6577991 [TBL] [Abstract][Full Text] [Related]
17. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
19. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499 [TBL] [Abstract][Full Text] [Related]
20. Plasma high-density-lipoprotein cholesterol levels during long-term use of an oral contraceptive in Nigerian women. Taylor GO; Agbedana EO; Ojo OA Br J Obstet Gynaecol; 1982 Nov; 89(11):944-7. PubMed ID: 7171504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]